Biofil Chemicals

29
Strong Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE829A01014
  • NSEID: BIOFILCHEM
  • BSEID: 524396
INR
34.70
0.5 (1.46%)
BSENSE

Dec 05

BSE+NSE Vol: 1.91 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is -16.57% vs 33.29% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 3.78% vs -30.07% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is -11.08% vs -2.35% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is -21.35% vs 26.55% in Mar 2024

Compare Profit and Loss Results of Biofil Chemicals
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
33.00
854.00
-821.00
-96.14%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
33.00
854.00
-821.00
-96.14%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
10.00
-10.00
-100.00%
Raw Materials Consumed
31.00
830.00
-799.00
-96.27%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
0.00
0.00
0.00
0%
Operating Expenses
0.00
1.00
-1.00
-100.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
0.00
0.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
32.00
844.00
-812.00
-96.21%
Operating Profit (PBDIT) excl Other Income
0.00
10.00
-10.00
-100.00%
Other Income
0.00
0.00
0.00
0%
Operating Profit (PBDIT)
1.00
10.00
-9.00
-90.00%
Interest
0.00
0.00
0.00
0%
Profit before Depriciation and Tax
1.00
10.00
-9.00
-90.00%
Depreciation
0.00
0.00
0.00
0%
Profit Before Taxation & Exceptional Items
0.00
10.00
-10.00
-100.00%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
0.00
10.00
-10.00
-100.00%
Provision for Tax
0.00
2.00
-2.00
-100.00%
Profit After Tax
0.00
7.00
-7.00
-100.00%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
-31.00
4.00
-35.00
-875.00%
Profit Available for appropriations
-31.00
11.00
-42.00
-381.82%
Appropriations
-31.00
11.00
-42.00
-381.82%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
0.34
0.04
0.30
750.00%
Profit And Loss - Net Sales
Net Sales 33.40 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -16.57% vs 33.29% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 0.85 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 3.78% vs -30.07% in Mar 2024

Profit And Loss - Interest
Interest 0.04 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -11.08% vs -2.35% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 0.56 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -21.35% vs 26.55% in Mar 2024